board of directors

Terry McGuire is a co-founder and managing general partner of Polaris Venture Partners, where he focuses on life sciences investments. Prior to starting Polaris, Mr. McGuire spent seven years at Burr, Egan, Deleage & Co. investing in early stage medical and information technology companies. Mr. McGuire began his career in venture capital at Golder, Thoma and Cressey in Chicago. Mr. McGuire has co-founded three companies: Inspire Pharmaceuticals, AIR (Advanced Inhalation Research, Inc.), acquired by Alkermes, Inc., and MicroCHIPS. Mr. McGuire represents Polaris on the boards of directors of Acceleron Pharma, Biolex Therapeutics, GlycoFi, Life Line Screening, Ironwood Pharmaceuticals, MicroCHIPS, Cerulean Pharma, and Trevena. He has also represented Polaris on the boards of Akamai, deCODE, Cubist Pharmaceuticals, Aspect Medical Systems, and Transform Pharmaceuticals. Mr. McGuire currently serves on the boards of the Thayer School of Engineering at Dartmouth College, the Whitehead Institute for Biomedical Research, and the Advisory Board of the Arthur Rock Center for Entrepreneurship at Harvard Business School. Mr. McGuire holds an M.B.A. from Harvard Business School, an M.S. in engineering from The Thayer School at Dartmouth College, and a B.S. in physics and economics from Hobart College.